Boston Children’s Hospital Launches Consortium to Develop Bioengineered Heart Tissues for Children
Researchers plan to test the engineered tissues first in the laboratory and then in large animals, and eventually in humans.
Category: News
BrightPath Presents Preclinical Data and Phase 1 Trial Design for iPSC-Derived CAR-iNKT Therapy for Multiple Myeloma
The planned trial is designed for patients whose multiple myeloma has returned or resisted treatment after at least three prior lines of therapy.
Century Therapeutics Reports Sustained Glucose Control With iPSC-Derived Islets in Diabetic Mice, IND Soon
In rats, islets delivered through the liver’s portal vein had taken hold one month later, supporting the delivery route planned for clinical testing.
Rivercell Launches With $25M to Build AI Models to Predict Human Cell Responses to Drugs and Genetic Changes
The company is developing a purpose-built laboratory platform to collect large-scale training data on how cells change over time and under treatment.
Vitalant Launches Phoenix Cell-Based Analytics Lab to Support Allogeneic Therapy Developers
Developers will have access to immune profiling and detailed donor assessments, intended to help them evaluate the starting material used to make donor-derived cell therapies.
Umbilical Cord Mesenchymal Stem Cell Injections Lower Pain Scores More Than Hyaluronate in 50-Patient Severe Knee Osteoarthritis Trial
Participants received either four stem cell injections two weeks apart or five weekly hyaluronate injections, with outcomes tracked for 12 months.
Stempeutics Nabs US Patent for Osteoarthritis Treatment Combining Bone Marrow Stem Cells and Hyaluronic Acid
The Indian biotech company previously published a Phase 3 RCT comparing its therapy to placebo in 146 KOA patients.
Wolwo Bio Subsidiary Receives Chinese Trial Authorization for Umbilical Cord Mesenchymal Stem Cell Therapy for Sepsis
The company hopes to nab the first approval in the world for this indication.
YiPSCELL Nabs $8M for iPSC-Derived Cartilage Regeneration
YiPSCELL's lead candidate delivers three-dimensional cartilage organoids derived from induced pluripotent stem cells through an injection into the joint cavity.
I Peace Wins Top 10 Longevity Breakthrough Award for Cell-Free Stem Cell Technology
The experimental product isolates and purifies factors released by lab-grown iPS-derived cells, with foundational studies examining age-related changes in tissues including skin and hair.